Household & Personal Products

Clorox’s $2.25 B buy of GOJO expands its hygiene dominance to 55% of the U.S. hand‑sanitizer market, delivering $150‑$170 M cash flow and smart‑dispenser synergies—but the debt‑backed deal adds 0.4x leverage risk that investors must watch closely.

Institutional investors are split on Kimberly‑Clark: some boost stakes amid cautious optimism, while others sell amid margin, ESG, and digital gaps that may curb growth.

Essity AB’s latest earnings show a modest EBITDA rise and a dividend hike, but falling sales keep investors wary as the company seeks to reverse revenue decline.

Institutional investors split on Kimberly‑Clark Corp., balancing gains and sales as macro‑economic trends shape consumer‑staples sentiment.

Church & Dwight’s recent institutional trades show routine adjustments, not a shift in fundamentals. UBS keeps a neutral stance while the company remains steady in household and personal‑care staples.

Unilever PLC keeps strong market momentum, with resilient demand and a big emerging‑market contract boosting growth and investor confidence.

Beiersdorf AG’s stable share price mirrors the DAX rise, highlighting its diversified personal‑care portfolio and resilient market position amid Germany’s economic optimism.

Henkel AG’s dual‑business model balances industrial adhesives with household staples, using R&D synergies to stay resilient amid German market shifts.

Discover how Kenvue’s dual‑brand hydration launch—ORSL and eRZL—targets India’s rising wellness market with science‑backed, low‑sugar drinks, while navigating strict FSSAI rules and competitive pricing.

Discover how L’Oréal’s €350 million Hyderabad hub and German market push reshape AI‑driven beauty, blending talent, tech and regulatory insight for growth.